While exploring innovative research and development efforts underway globally, presenters will highlight the urgent need for vigilance with regard to “nanotoxicity.” Ethical, business, FDA and patent law issues will be examined to ensure a fruitful future for the science of manipulating and building at the molecular level.

This annual conference, now in its seventh year, will be held at Rensselaer Polytechnic Institute in Troy, New York, USA on October 19, 2009. It will be multi-disciplinary in nature, and as always, expected to attract world-wide participation for its in-depth focus on pharma, nanomedicine, engineering and biotechnology. CEOs from early stage New York companies successfully commercializing a university invention will also be invited.